CAWS MÔN LIMITED

Company number 14932219 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

CAWS MÔN LIMITED - Analysis Report

Company Number: 14932219

Analysis Date: 2025-07-20 14:48 UTC

Financial Health Score: D

Explanation: CAWS MÔN LIMITED is a very young micro-entity company with minimal financial activity to date, reflected in a very limited asset base (£100 net assets) and no recorded revenues, expenses, or liabilities. The score reflects an early-stage company showing "symptoms of dormancy" rather than active healthy financial operations. There is no cash flow, no current assets, and no liabilities reported, indicating minimal or no trading activity so far.


Key Vital Signs

Metric Value Interpretation
Company Age 1.5 years Very new company, still in early development phase
Account Category Micro Minimal filing requirements; indicates small scale of operations
Net Assets £100 Extremely low equity base; essentially initial share capital only
Current Assets £0 No cash, receivables, or inventory – potential "no cash flow" symptom
Current Liabilities £0 No short-term debts; could mean no trading or payables yet
Net Current Assets £0 Neutral working capital – no liquidity buffer or operational activity
Employees 0 No staff employed, indicating limited or no operational activity
Directors 1 current Leadership in place but one director resigned recently
Previous Name Change Yes, recently Rebranding or restructuring may indicate early business model adjustments
Industry Classification Butter and cheese production (SIC 10512) Sector with physical production requirements, but no assets or employees yet

Symptoms Analysis

  • No operational trading signs: The absence of current assets, liabilities, and employees suggests the business has not yet commenced significant trading or production activities.
  • Minimal capital base: Net assets of £100 reflect only the initial share capital, with no retained earnings or profits, indicating no financial generation.
  • No liquidity or cash flow: Zero current assets mean there is no cash or equivalents, which is critical "vital sign" for operational health. Without cash or receivables, the company cannot meet operational expenses or invest in growth.
  • Early stage setup: The recent incorporation (June 2023) and micro-entity status means it is likely still in setup or planning phase, which is typical but requires monitoring.
  • Director change: One director resigned within the first year, which could be normal but should be monitored for governance stability.

Diagnosis

CAWS MÔN LIMITED exhibits characteristics of a pre-operational or dormant micro-entity. Its financial "vital signs" indicate no active business operations, no employees, no trading, and only nominal equity. The absence of cash or working capital poses a risk if the company intends to commence production soon without additional funding. While not showing distress (no liabilities or negative equity), it lacks the "healthy cash flow" and operational metrics needed for sustainable business growth.


Prognosis

If the company plans to begin butter and cheese production soon, it will require significant capital infusion, asset acquisition, and working capital management to build healthy financial "vital signs." Without this, it risks stagnation or inability to meet operational needs. Close attention to cash flow management and capital funding will be critical in the near term to transition from setup to active trading.


Recommendations

  1. Capital Injection: Secure sufficient funding to purchase necessary fixed assets (equipment, premises) and cover initial operational costs.
  2. Cash Flow Planning: Develop a detailed cash flow forecast to ensure liquidity is maintained as production begins.
  3. Operational Setup: Consider hiring key personnel or contractors to support production activities.
  4. Financial Monitoring: Implement regular financial reviews to track asset acquisition, liabilities, and working capital changes.
  5. Governance Stability: Maintain active and engaged directors to ensure sound management and compliance.
  6. Business Plan Review: Reassess market strategy and production timelines to align financial needs with operational goals.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.